Detalhe da pesquisa
1.
Developing Folate-Conjugated miR-34a Therapeutic for Prostate Cancer: Challenges and Promises.
Int J Mol Sci
; 25(4)2024 Feb 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38396800
2.
STAT3/LKB1 controls metastatic prostate cancer by regulating mTORC1/CREB pathway.
Mol Cancer
; 22(1): 133, 2023 08 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37573301
3.
Developing folate-conjugated miR-34a therapeutic for prostate cancer treatment: Challenges and promises.
bioRxiv
; 2024 Jan 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38045265
4.
MicroRNA-34a, Prostate Cancer Stem Cells, and Therapeutic Development.
Cancers (Basel)
; 14(18)2022 Sep 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-36139695
5.
Prostate cancer as a dedifferentiated organ: androgen receptor, cancer stem cells, and cancer stemness.
Essays Biochem
; 66(4): 291-303, 2022 09 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35866337
6.
MicroRNA-34a: Potent Tumor Suppressor, Cancer Stem Cell Inhibitor, and Potential Anticancer Therapeutic.
Front Cell Dev Biol
; 9: 640587, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33763422